1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 07 SEPTEMBER 2015

Cancer Drug News 07 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - ADCs Returning To Forefront Of Oncology Drug Development
Industry Brief - FDA Accepts Empliciti For Priority Review
Industry Brief - FDA Accepts sBLA For Opdivo In Previously Treated Non-Squamous NSCLC
Industry Brief - MHLW Lifts All-Case Surveillance Condition For Eisai's Gliadel Implant
Industry Brief - Tafinlar+Mekinist Gains EU Approval For Advanced Melanoma
Industry Brief - NHS England Delists 16 Drugs From CDF
Industry Brief - FDA Grants Loxo Soft Tissue Sarcoma Drug ODD
Industry Trend Analysis - Incyte Faces Difficulty In Breaking Checkpoint Inhibitor Market
Industry Trend Analysis - Tesaro's First Drug Faces Battle For Position In Congested CINV Market
Industry Brief - FDA Approves Paediatric Indication For Emend
Industry Brief - Enrolment Completed In SGX942 Phase II Trial For Oral Mucositis In H&N Cancer
Industry Trend Analysis - BMS Aiming For Long-Term Immuno-oncology Dominance

Table Of Contents

Cancer Drug News 07 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.